1
|
Woelber L, Kock L, Gieseking F, Petersen
C, Trillsch F, Choschzick M, Jaenicke F and Mahner S: Clinical
management of primary vulvar cancer. Eur J Cancer. 47:2315–2321.
2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kajal B, Talati H, Daya D and Alowami S:
Apocrine adenocarcinoma of the vulva. Rare Tumors. 5:e402013.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Bogani G, Uccella S, Cromi A, Casarin J,
Donadello N and Ghezzi F: Primary mammary-like ductal carcinoma of
the vulva: A case report and analysis of the literature. Am J
Dermatopathol. 35:685–687. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ghamande SA, Kasznica J, Griffiths CT,
Finkler NJ and Hamid AM: Mucinous adenocarcinomas of the vulva.
Gynecol Oncol. 57:117–120. 1995. View Article : Google Scholar : PubMed/NCBI
|
5
|
Cormio G, Carriero C, Loizzi V, Gissi F,
Leone L, Putignano G, Resta L and Selvaggi L: ‘Intestinal-type’
mucinous adenocarcinoma of the vulva: A report of two cases. Eur J
Gynaecol Oncol. 33:433–435. 2012.PubMed/NCBI
|
6
|
Geisler JP, Manahan KJ and Buller RE:
Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary
exenteration. Gynecol Oncol. 100:53–57. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Mendoza S and Helwig EB: Mucinous
(adenocystic) carcinoma of the skin. Arch Dermatol. 103:68–78.
1971. View Article : Google Scholar : PubMed/NCBI
|
8
|
Rahilly MA, Beattie GJ and Lessells AM:
Mucinous eccrine carcinoma of the vulva with neuroendocrine
differentiation. Histopathology. 27:82–86. 1995. View Article : Google Scholar : PubMed/NCBI
|
9
|
Graf AH, Su HC, Tubbs RR, Hacker GW, Dietz
O and Staudach A: Primary neuroendocrine differentiated mucinous
adenocarcinoma of the vulva: case report and review of the
literature. Anticancer Res. 18:2041–2045. 1998.PubMed/NCBI
|
10
|
Magrina JF, Gonzalez-Bosquet J, Weaver AL,
Gaffey TA, Webb MJ, Podratz KC and Cornella JL: Primary squamous
cell cancer of the vulva: Radical versus modified radical vulvar
surgery. Gynecol Oncol. 71:116–121. 1998. View Article : Google Scholar : PubMed/NCBI
|
11
|
Woelber L, Trillsch F, Kock L, Grimm D,
Petersen C, Choschzick M, Jaenicke F and Mahner S: Management of
patients with vulvar cancer: A perspective review according to
tumour stage. Ther Adv Med Oncol. 5:183–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Dittmer C, Fischer D, Diedrich K and Thill
M: Diagnosis and treatment options of vulvar cancer: A review. Arch
Gynecol Obstet. 285:183–193. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Woelber L, Mahner S, Voelker K, Eulenburg
CZ, Gieseking F, Choschzick M, Jaenicke F and Schwarz J:
Clinicopathological prognostic factors and patterns of recurrence
in vulvar cancer. Anticancer Res. 29:545–552. 2009.PubMed/NCBI
|
14
|
Domingues AP, Mota F, Durão M, Frutuoso C,
Amaral N and de Oliveira CF: Neoadjuvant chemotherapy in advanced
vulvar cancer. Int J Gynecol Cancer. 20:294–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Stehman FB and Look KY: Carcinoma of the
vulva. Obstet Gynecol. 107:719–733. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Herr D, Juhasz-Boess I and Solomayer EF:
Therapy for primary vulvar carcinoma. Geburtshilfe Frauenheilkd.
74:271–275. 2014. View Article : Google Scholar : PubMed/NCBI
|